# Cordis US Corp. clinical trials: 78 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 78 trials with Cordis US Corp. as lead sponsor, 2 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Cordis US Corp.: 78 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/cordis-us-corp

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 78
- Recruiting or not yet: 2
- Read on: November 19, 2026

## Trials

The 25 newest of 78, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| January 14, 2026 | NCT07338890 | Post-Market Clinical Follow-Up of S.M.A.R.T. Family of Stents in Treating Iliac and Femoropopliteal Artery Disease | Cordis US Corp. | Observational | Not yet recruiting | Superficial Femoral Artery Stenosis, Iliac Artery Stenosis, Popliteal Artery Stenosis | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07338890) |
| November 24, 2025 | NCT07246902 | Mobilization and Outcomes After Venous Closure | Cordis US Corp. | Observational | Completed | Venous Vascular Closure, Electrophysiology Study | 339 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07246902) |
| October 2, 2025 | NCT07204678 | PMCF Study of Precise Pro Rx for Carotid Artery Disease | Cordis US Corp. | Observational | Completed | Carotid Artery Stenosis | 199 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07204678) |
| August 14, 2025 | NCT07122518 | Post-Approval Study of PALMAZ MULLINS XD™ in Treating Pulmonary Artery Stenosis | Cordis US Corp. | Observational | Recruiting | Pulmonary Artery Stenosis | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07122518) |
| September 26, 2022 | NCT05554471 | Evaluation of Safety and Efficacy of the Mynx Control Venous Vascular Closure Device 6F-12F vs Manual Compression | Cordis US Corp. | Not applicable | Completed | Venous Vascular Closure | 352 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05554471) |
| September 16, 2022 | NCT05543096 | PMCF Study for Cardiology Access Procedures | Cordis US Corp. | Observational | Completed | Coronary Artery Disease | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05543096) |
| July 6, 2022 | NCT05444660 | PMCF Study for Peripheral Arteries Below the Knee (BTK) | Cordis US Corp. | Observational | Completed | Peripheral Artery Disease | 102 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05444660) |
| June 1, 2022 | NCT05399680 | Evaluation of Safety and Efficacy of the S.M.A.R.T. RADIANZ™ Vascular Stent System in the Treatment of Iliac and Femoropopliteal Lesions... | Cordis US Corp. | Not applicable | Completed | Peripheral Arterial Disease | 151 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05399680) |
| April 5, 2022 | NCT05312580 | PMCF Study for Peripheral Arteries Above the Knee (ATK) | Cordis US Corp. | Observational | Completed | Peripheral Arterial Disease, Femoropopliteal Stenosis, Angiopathy, Peripheral | 387 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05312580) |
| May 29, 2019 | NCT03965364 | China Post-market Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic Aneurysms (INITIATION) | Cordis US Corp. | Observational | Withdrawn | Abdominal Aortic Aneurysms | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03965364) |
| April 22, 2019 | NCT03923387 | Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure Device | Cordis US Corp. | Not applicable | Completed | Endovascular | 306 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03923387) |
| June 22, 2015 | NCT02477111 | European (EU) Post Approval Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic Aneurysms | Cordis US Corp. | Observational | Completed | Abdominal Aortic Aneurysms | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02477111) |
| January 28, 2013 | NCT01776450 | Compassionate Use of the Incraft® AAA Stent Graft System | Cordis US Corp. | Not applicable | No longer available | Abdominal Aortic Aneurysm | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01776450) |
| August 14, 2012 | NCT01664078 | A Multicenter, Open Label, Prospective, Non-randomized Study of the InCraft® Stent Graft System in Subjects With Abdominal Aortic Aneurysms... | Cordis US Corp. | Not applicable | Completed | Abdominal Aortic Aneurysm | 190 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01664078) |
| May 18, 2011 | NCT01355406 | Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System | Cordis US Corp. | Not applicable | Completed | Peripheral Artery Disease, Peripheral Vascular Disease, Vascular Disease, Cardiovascular Diseases, PAD | 257 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01355406) |
| September 15, 2010 | NCT01202058 | An Observational Safety Evaluation of Patients Treated With the NEVO™ Sirolimus-eluting Coronary Stent. (NEVO II) | Cordis US Corp. | Phase 3 | Terminated | Atherosclerotic Coronary Artery Disease | 156 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01202058) |
| April 19, 2010 | NCT01106391 | A Multicenter, Open Label, Prospective, Non-Randomized Study Of INCRAFT™ In Subjects With AAA (INNOVATION) | Cordis US Corp. | Not applicable | Completed | Abdominal Aortic Aneurysms | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01106391) |
| April 19, 2010 | NCT01106378 | Cynergy: the CYPHER-NEVO Registry | Cordis US Corp. | Observational | Terminated | Coronary Artery Disease | 14,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01106378) |
| September 10, 2009 | NCT00974181 | The European Cobalt STent With Antiproliferative for Restenosis Trial (EuroSTAR Trial) | Cordis US Corp. | Phase 3 | Completed | Treatment of Symptomatic Ischemic Heart Disease | 282 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00974181) |
| August 7, 2009 | NCT00954707 | CYPRESS - CYPHER for Evaluating Sustained Safety | Cordis US Corp. | Phase 4 | Unknown | Coronary Artery Disease | 2,509 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00954707) |
| March 4, 2009 | NCT00855478 | French Post-Marketing Surveillance Survey | Cordis US Corp. | Phase 4 | Terminated | Coronary Artery Disease | 4,080 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00855478) |
| September 9, 2008 | NCT00749424 | The Study of the Crushing Technique Application Using SES in Coronary Bifurcations. | Cordis US Corp. | Phase 4 | Completed | Coronary Artery Disease | 350 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00749424) |
| August 21, 2008 | NCT00739102 | S.M.A.R.T.® Nitinol Self-Expandable Stent in the Treatment of Obstructive Superficial Femoral Artery Disease | Cordis US Corp. | Not applicable | Completed | Superficial Femoral Artery Disease | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00739102) |
| July 25, 2008 | NCT00722579 | A Study of the Presillion Stent in de Novo Coronary Lesions | Cordis US Corp. | Phase 3 | Completed | Coronary Artery Disease | 101 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00722579) |
| July 15, 2008 | NCT00715884 | Study Comparing the CYPHER® ELITE™ to the CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent Systems | Cordis US Corp. | Not applicable | Unknown | Coronary Artery Disease, Coronary Atherosclerosis | 678 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00715884) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 1 |
| Phase 1/2 | 7 |
| Phase 2 | 8 |
| Phase 2/3 | 2 |
| Phase 3 | 19 |
| Phase 4 | 18 |
| Not applicable | 10 |
| Observational | 13 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 65 |
| Terminated | 7 |
| Unknown | 2 |
| No longer available | 1 |
| Recruiting | 1 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Coronary Artery Disease | 41 |
| Aortic Aneurysm, Abdominal | 7 |
| Peripheral Arterial Disease | 6 |
| Coronary Disease | 5 |
| Arterial Occlusive Diseases | 4 |
| Atherosclerosis | 3 |
| Carotid Artery Diseases | 3 |
| Peripheral Arterial Occlusive Disease 1 | 3 |
| Peripheral Vascular Diseases | 3 |
| Cardiovascular Diseases | 2 |
| Vascular Diseases | 2 |
| Stenosis, Pulmonary Artery | 1 |
| Carotid Stenosis | 1 |
| Pulmonary Embolism | 1 |
| Arteriosclerosis | 1 |
| Renal Artery Obstruction | 1 |
| Coronary Stenosis | 1 |
| Myocardial Ischemia | 1 |
| Heart Diseases | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Child care centers in the United States](https://specstream.ai/data/businesses/child-care-centers/united-states)
- [Plastic injection molders in the United States](https://specstream.ai/data/businesses/plastic-injection-molders/united-states)
- [Computer hardware companies in the United States](https://specstream.ai/data/businesses/computer-hardware-companies/united-states)
- [Product design firms in the United States](https://specstream.ai/data/businesses/product-design-firms/united-states)
- [Day care centers in the United States](https://specstream.ai/data/businesses/day-care-centers/united-states)
- [Records storage companies in the United States](https://specstream.ai/data/businesses/records-storage-companies/united-states)
